SCHEMBL17947668

SCHEMBL17947668

Cc1ccc(N2c3cccc(C#N)c3N(C)[C@@H]2C)c(C)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NOTUM Q6P988 1/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ ALOX12 P18054 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ CYP1A2 P05177 3/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ HBB P68871 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17947665 0.90 ALDH1A1 (0.34) KDM4ETSHRNOTUMALDH1A1KMT2A
SCHEMBL17952168 0.90 NPSR1 (0.33) NPSR1KDM4ETSHRNOTUMALDH1A1
SCHEMBL17947330 0.87 KDM4E (0.33) KDM4ETSHRNOTUMALDH1A1KMT2A
SCHEMBL17947374 0.87 TSHR (0.34) KDM4ETSHRNOTUMALDH1A1KMT2A
SCHEMBL17947375 0.87 KDM4E (0.37) KDM4ETSHRNOTUMALDH1A1KMT2A
SCHEMBL17947667 0.87 TSHR (0.43) NPSR1KDM4ETSHRNOTUMALDH1A1
SCHEMBL17947663 0.85 SMN1; SMN2 (0.36) KDM4ETSHRNOTUMALDH1A1HIF1A
SCHEMBL17952390 0.85 NPSR1 (0.36) NPSR1KDM4ETSHRALDH1A1KMT2A
SCHEMBL17952110 0.85 NPSR1 (0.33) NPSR1ALDH1A1LMNAATMHTR7
SCHEMBL17952326 0.84 NPSR1 (0.33) NPSR1KDM4EALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10418569-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-17 — — US disclosed
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-28 — — US disclosed
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10418569-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP2 NPSR1 1465/4885KDM4E 4426/4885TSHR 4400/4885
US-20160218303-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OSBP2 NPSR1 1465/4885KDM4E 4426/4885TSHR 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback